Annual Congress: Hematologic Malignancies
Registration Now Open!
NCCN 2021 Virtual Congress: Hematologic Malignancies™
Thursday, October 14, 2021 – Saturday, October 16, 2021
NCCN Virtual Congress registration fees include:
- Access to all live and recorded congress sessions, including interactive question and answer opportunities with speakers during the live event.
- Active participation within the Digitell platform during the congress and 60 days following the event, allowing time to review sessions you may have missed or revisit sessions important to your practice.
- Exclusive access to the Virtual Exhibition Hall. Attendees can participate in live chats, download resources and videos, attend product showcases, and set up one-on-one meetings with exhibitors.
Attention NCCN Member Institution Professionals!
NCCN is offering complimentary registrations to healthcare professionals employed at our NCCN Member Institutions. For immediate access to this discount code and to continue your complimentary registration, please login to the NCCN Member Portal.
Members of the Media: Please contact Rachel Darwin.
Continuing Education
New format this year! The event has expanded to three days of interactive presentations for a variety of hematologic malignancies. Co-chairs Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center,
will lead expert discussions on the latest advances, updates to the NCCN Guidelines®, and unique and challenging patient cases.
Agenda topics include:
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Chronic Myeloid Leukemia
- Diffuse Large B-Cell Lymphoma
- Follicular Lymphoma
- Histiocytic Neoplasms
- Hodgkin Lymphoma
- Mantle Cell Lymphoma
- Marginal Zone Lymphomas
- Monoclonal Gammopathy of Clinical Significance
- Multiple Myeloma
- Myeloproliferative Neoplasms
- Non-Hodgkin Lymphomas
- Plasma Cell Neoplasms
- Peripheral T-Cell Lymphomas
- Systemic Light Chain Amyloidosis
- Waldenström Macroglobulinemia
Accreditation
This program is approved for AMA PRA Category 1 Credit™ for physicians and will award contact hours for nurses, pharmacists, and other health care professionals.
Virtual Exhibition Hall
Visit the NCCN Virtual Exhibition Hall and Patient Advocacy Pavilion! Congress attendees can participate in live chats, download resources and videos, attend product showcases, and set up one-on-one meetings with exhibitors.
Exhibitor Information
View Sponsor and Exhibitor Prospectus
Supporters
Supported by educational grants from AstraZeneca; Daiichi Sankyo; Gilead Sciences, Inc. and Kite, A Gilead Company; GlaxoSmithKline; Novartis; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer Inc.; Seagen Inc. (formerly Seattle Genetics, Inc.); and Takeda. This educational activity is supported by a medical education grant from Karyopharm® Therapeutics. This activity is supported by independent medical education grants from ADC Therapeutics, Pharmacyclics LLC and Janssen and Jazz Pharmaceuticals. This activity is supported by an independent educational grant from Merck & Co., Inc.
Commercial Sponsors
Gold Level Sponsors
Incyte
Janssen Oncology
Silver Level Sponsors
AstraZeneca
Oncopeptides
Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc.
Bronze Level Sponsors
AbbVie
Astellas
Jazz Pharmaceuticals
Karyopharm Therapeutics, Inc.
Spectrum
Supporter Opportunities
Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio.
Sponsorship and exhibit opportunities are available. For more information, contact Jennifer Tredwell.
Virtual Nursing Forum
Friday, October 8, 2021
This program provides hematology/oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.
The NCCN 2020 Virtual Congress: Hematologic Malignancies™ and NCCN Virtual Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ were held October 8 – 10, 2020. These programs focused on updates to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®); new, emerging and novel therapeutic agents; advances in cancer care; and the practical management of patients with hematologic malignancies.
View Recorded Sessions
CE-certified recorded sessions are available at education.nccn.org/forum2020 and education.nccn.org/hem2020!
Those who attended the virtual events will be able to access session recordings, exhibition hall information, and other features in the Pathable platform through August 2021. Please email conferences@nccn.org with questions.
Save the dates!
NCCN 2022 Annual Congress: Hematologic Malignancies™New York Marriott Marquis • New York, New York
Friday, October 14, 2022 – Saturday, October 15, 2022
NCCN 2023 Annual Congress: Hematologic Malignancies™
Hilton San Francisco Union Square • San Francisco, California
Friday, September 22, 2023 – Saturday, September 23, 2023